Anan, Tokushima, Japan
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
Phase
2Span
126 weeksSponsor
Merck Sharp & Dohme LLCAnan, Tokushima
Recruiting
1-1 of 1